Department of Clinical Sciences, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
J Intern Med. 2011 Mar;269(3):289-98. doi: 10.1111/j.1365-2796.2010.02280.x. Epub 2010 Sep 10.
To investigate how the timing of dialysis initiation is associated with mortality.
Population-based, prospective, observational cohort study.
Clinical laboratories (n = 69) provided information on all patients in Sweden whose serum creatinine level for the first time and exceeded 3.4 mg dL(-1) (men) or 2.8 mg dL(-1) (women) between 20 May 1996 and 31 May 1998.
All patients (n = 901), aged 18-74 years, in whom the cause of serum creatinine elevation was chronic kidney disease, were included in the study; participants were interviewed and followed for 5-7 years.
Information on date of death was obtained from a national Swedish population register. Early-start dialysis [estimated glomerular filtration rate from serum creatinine (eGFR) ≥7.5 mL min(-1) per 1.73 m(2)] was compared to late start of dialysis (eGFR <7.5 mL min(-1) per 1.73 m(2)), and no dialysis. Relative risk [hazard ratio (HR)] of death was modelled with time-dependent multivariate Cox proportional hazards regression.
Mean eGFR was 16.1 mL min(-1) per 1.73 m(2) at inclusion and 7.6 mL min(-1) per 1.73 m(2) at the start of dialysis. Among the 385 patients who started dialysis late, 36% died during follow-up compared to 52% of 323 who started early. The adjusted HR for death was 0.84 [95% confidence interval (CI) 0.64, 1.10] among late versus early starters. The mortality among nondialysed patients increased significantly at eGFR below 7.5 mL min(-1) per 1.73 m(2) (HR 4.65; 95% CI 2.28, 9.49; compared to eGFR 7.5-10 mL min(-1) per 1.73 m(2)). After the start of dialysis, the mortality rate further increased. Compared to nondialysed patients with eGFR ≤15 mL min(-1) per 1.73 m(2), adjusted HR was 2.65 (95% CI 1.80, 3.89) for patients receiving dialysis.
We found no survival benefit from early initiation of dialysis.
探讨透析开始时间与死亡率之间的关系。
基于人群的前瞻性观察队列研究。
临床实验室(n=69)提供了 1996 年 5 月 20 日至 1998 年 5 月 31 日期间血清肌酐水平首次超过 3.4mg/dL(男性)或 2.8mg/dL(女性)的所有瑞典患者的所有信息。
所有年龄在 18-74 岁之间,血清肌酐升高的病因是慢性肾脏病的患者(n=901)均纳入本研究;对参与者进行了访谈并随访了 5-7 年。
从一个全国性的瑞典人口登记处获得有关死亡日期的信息。早期开始透析(估计肾小球滤过率[eGFR]≥7.5mL min(-1) per 1.73 m(2))与晚期开始透析(eGFR<7.5mL min(-1) per 1.73 m(2))和无透析进行比较。使用时间依赖性多变量 Cox 比例风险回归模型来模拟死亡的相对风险[危险比(HR)]。
纳入时平均 eGFR 为 16.1mL min(-1) per 1.73 m(2),开始透析时为 7.6mL min(-1) per 1.73 m(2)。在 385 名开始透析较晚的患者中,36%在随访期间死亡,而 323 名开始透析较早的患者中有 52%死亡。晚期开始与早期开始相比,死亡的调整 HR 为 0.84(95%置信区间[CI]0.64,1.10)。eGFR 低于 7.5mL min(-1) per 1.73 m(2)时,未接受透析患者的死亡率显著增加(HR 4.65;95%CI 2.28,9.49;与 eGFR 7.5-10mL min(-1) per 1.73 m(2)相比)。开始透析后,死亡率进一步增加。与 eGFR≤15mL min(-1) per 1.73 m(2)的未接受透析患者相比,接受透析的患者调整后的 HR 为 2.65(95%CI 1.80,3.89)。
我们没有发现早期开始透析有生存获益。